Novo Nordisk Forges Multiple Partnerships To Sell Obesity Drug Wegovy At A Discount
forbes.com/sites/joshuacohen/2025/05/01/novo-nordisk-forges-multiple-partnerships-to-sell-obesity-drug-wegovy-at-a-discount
The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli Lilly in the lucrative obesity drug market.
This story appeared on forbes.com, 2025-05-01 22:06:28.